|
U.S. FDA May Miss MDUFMA Deadline, Industry Sees Progress
The U.S. device industry and the U.S. Food and Drug Administration (FDA) are closer to an agreement on reauthorizing the Medical Device User Fee and Modernization Act (MDUFMA), but chances are slim that the agency will meet a Jan. 15 goal to deliver that agreement to Congress.
This article is viewable by subscribers only. To view this article, please select an option below.
|
|
Subscribe
Archives